Here, a 77-year-old woman was diagnosed with stage IVA lung adenocarcinoma harboring a novel low-density lipoprotein receptor (<i>LDLR</i>)<i>-ROS1</i> fusion variant. Here, ROS1 is linked to lung adenocarcinoma.